25 XP   0   0   10

Universal Med Finl &
Buy, Hold or Sell?

Let's analyse Universal Med Finl & together

PenkeI guess you are interested in Universal Med Finl &. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Universal Med Finl &. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Universal Med Finl &

I send you an email if I find something interesting about Universal Med Finl &.

Quick analysis of Universal Med Finl & (30 sec.)










What can you expect buying and holding a share of Universal Med Finl &? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$8.94
Expected worth in 1 year
HK$10.91
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
HK$3.30
Return On Investment
70.6%

For what price can you sell your share?

Current Price per Share
HK$4.68
Expected price per share
HK$4.34 - HK$5.0110554493308
How sure are you?
50%

1. Valuation of Universal Med Finl & (5 min.)




Live pricePrice per Share (EOD)

HK$4.68

Intrinsic Value Per Share

HK$16.54 - HK$30.75

Total Value Per Share

HK$25.47 - HK$39.68

2. Growth of Universal Med Finl & (5 min.)




Is Universal Med Finl & growing?

Current yearPrevious yearGrowGrow %
How rich?$2.1b$2b$119.3m5.5%

How much money is Universal Med Finl & making?

Current yearPrevious yearGrowGrow %
Making money$270.6m$268.7m$1.8m0.7%
Net Profit Margin16.5%19.6%--

How much money comes from the company's main activities?

3. Financial Health of Universal Med Finl & (5 min.)




4. Comparing to competitors in the Credit Services industry (5 min.)




  Industry Rankings (Credit Services)  


Richest
#34 / 249

Most Revenue
#20 / 249

Most Profit
#22 / 249

Most Efficient
#110 / 249

What can you expect buying and holding a share of Universal Med Finl &? (5 min.)

Welcome investor! Universal Med Finl &'s management wants to use your money to grow the business. In return you get a share of Universal Med Finl &.

What can you expect buying and holding a share of Universal Med Finl &?

First you should know what it really means to hold a share of Universal Med Finl &. And how you can make/lose money.

Speculation

The Price per Share of Universal Med Finl & is HK$4.68. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Universal Med Finl &.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Universal Med Finl &, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$8.94. Based on the TTM, the Book Value Change Per Share is HK$0.49 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.33 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Universal Med Finl &.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.142.9%0.142.9%0.132.9%0.122.6%0.091.8%
Usd Book Value Change Per Share0.061.3%0.061.3%-0.01-0.3%0.122.5%0.112.4%
Usd Dividend Per Share0.040.9%0.040.9%0.040.8%0.030.7%0.020.4%
Usd Total Gains Per Share0.112.3%0.112.3%0.020.4%0.153.2%0.132.9%
Usd Price Per Share0.60-0.60-0.72-0.71-0.61-
Price to Earnings Ratio4.39-4.39-5.37-6.08-7.06-
Price-to-Total Gains Ratio5.74-5.74-34.74-10.35-9.87-
Price to Book Ratio0.53-0.53-0.67-0.73-0.89-
Price-to-Total Gains Ratio5.74-5.74-34.74-10.35-9.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.597168
Number of shares1674
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.060.12
Usd Total Gains Per Share0.110.15
Gains per Quarter (1674 shares)176.46254.55
Gains per Year (1674 shares)705.851,018.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12844226962217971008
2567845140244215952026
38511267210866323923044
411341689281488431894062
5141821123520110539865080
6170125344226132647846098
7198529564932154655817116
8226833795638176763788134
9255238016344198871759152
102835422370502209797310170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%

Fundamentals of Universal Med Finl &

About Universal Med Finl &

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance Business and Hospital Group Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group Business segment engages in the provision of medical services; hospital and healthcare management; and import, export, and domestic trading of medical-related goods. The company is also involved in the provision of medical technology; construction and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-16 09:53:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Universal Med Finl &.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Universal Med Finl & earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • A Net Profit Margin of 16.5% means that $0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Universal Med Finl &:

  • The MRQ is 16.5%. The company is making a huge profit. +2
  • The TTM is 16.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.5%TTM16.5%0.0%
TTM16.5%YOY19.6%-3.2%
TTM16.5%5Y22.3%-5.8%
5Y22.3%10Y26.9%-4.6%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ16.5%13.7%+2.8%
TTM16.5%14.7%+1.8%
YOY19.6%18.4%+1.2%
5Y22.3%16.4%+5.9%
10Y26.9%15.5%+11.4%
1.1.2. Return on Assets

Shows how efficient Universal Med Finl & is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • 2.6% Return on Assets means that Universal Med Finl & generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Universal Med Finl &:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.6%0.0%
TTM2.6%YOY2.8%-0.2%
TTM2.6%5Y2.8%-0.2%
5Y2.8%10Y2.8%-0.1%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%0.9%+1.7%
TTM2.6%1.0%+1.6%
YOY2.8%0.9%+1.9%
5Y2.8%0.9%+1.9%
10Y2.8%0.8%+2.0%
1.1.3. Return on Equity

Shows how efficient Universal Med Finl & is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • 12.5% Return on Equity means Universal Med Finl & generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Universal Med Finl &:

  • The MRQ is 12.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.5%TTM12.5%0.0%
TTM12.5%YOY13.2%-0.6%
TTM12.5%5Y13.5%-1.0%
5Y13.5%10Y15.3%-1.8%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ12.5%3.4%+9.1%
TTM12.5%3.5%+9.0%
YOY13.2%3.7%+9.5%
5Y13.5%3.3%+10.2%
10Y15.3%3.6%+11.7%

1.2. Operating Efficiency of Universal Med Finl &.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Universal Med Finl & is operating .

  • Measures how much profit Universal Med Finl & makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Universal Med Finl &:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y22.7%-22.7%
5Y22.7%10Y28.2%-5.5%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.0%-21.0%
TTM-20.1%-20.1%
YOY-28.4%-28.4%
5Y22.7%21.9%+0.8%
10Y28.2%26.1%+2.1%
1.2.2. Operating Ratio

Measures how efficient Universal Med Finl & is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Credit Services industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are $1.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Universal Med Finl &:

  • The MRQ is 1.342. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.342. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.3420.000
TTM1.342YOY1.253+0.089
TTM1.3425Y1.008+0.334
5Y1.00810Y0.834+0.174
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3420.817+0.525
TTM1.3420.811+0.531
YOY1.2530.795+0.458
5Y1.0080.766+0.242
10Y0.8340.734+0.100

1.3. Liquidity of Universal Med Finl &.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Universal Med Finl & is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Credit Services industry mean).
  • A Current Ratio of 2.63 means the company has $2.63 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Universal Med Finl &:

  • The MRQ is 2.635. The company is able to pay all its short-term debts. +1
  • The TTM is 2.635. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.635TTM2.6350.000
TTM2.635YOY3.444-0.809
TTM2.6355Y1.836+0.799
5Y1.83610Y1.581+0.255
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6352.571+0.064
TTM2.6353.112-0.477
YOY3.4442.373+1.071
5Y1.8363.978-2.142
10Y1.5814.043-2.462
1.3.2. Quick Ratio

Measures if Universal Med Finl & is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Universal Med Finl &:

  • The MRQ is 1.002. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.002. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.002TTM1.0020.000
TTM1.002YOY1.249-0.246
TTM1.0025Y2.172-1.170
5Y2.17210Y2.401-0.229
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0021.736-0.734
TTM1.0021.975-0.973
YOY1.2491.758-0.509
5Y2.1723.594-1.422
10Y2.4013.498-1.097

1.4. Solvency of Universal Med Finl &.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Universal Med Finl & assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Universal Med Finl & to Credit Services industry mean.
  • A Debt to Asset Ratio of 0.80 means that Universal Med Finl & assets are financed with 79.7% credit (debt) and the remaining percentage (100% - 79.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Universal Med Finl &:

  • The MRQ is 0.797. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.797. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.797TTM0.7970.000
TTM0.797YOY0.789+0.008
TTM0.7975Y0.779+0.018
5Y0.77910Y0.796-0.017
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7970.729+0.068
TTM0.7970.714+0.083
YOY0.7890.717+0.072
5Y0.7790.703+0.076
10Y0.7960.693+0.103
1.4.2. Debt to Equity Ratio

Measures if Universal Med Finl & is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • A Debt to Equity ratio of 391.8% means that company has $3.92 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Universal Med Finl &:

  • The MRQ is 3.918. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.918. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.918TTM3.9180.000
TTM3.918YOY3.734+0.184
TTM3.9185Y3.813+0.105
5Y3.81310Y4.324-0.511
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9182.541+1.377
TTM3.9182.308+1.610
YOY3.7342.357+1.377
5Y3.8132.420+1.393
10Y4.3242.389+1.935

2. Market Valuation of Universal Med Finl &

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Universal Med Finl & generates.

  • Above 15 is considered overpriced but always compare Universal Med Finl & to the Credit Services industry mean.
  • A PE ratio of 4.39 means the investor is paying $4.39 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Universal Med Finl &:

  • The EOD is 4.332. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.387. Based on the earnings, the company is cheap. +2
  • The TTM is 4.387. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.332MRQ4.387-0.056
MRQ4.387TTM4.3870.000
TTM4.387YOY5.366-0.979
TTM4.3875Y6.083-1.696
5Y6.08310Y7.062-0.979
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
EOD4.3327.187-2.855
MRQ4.3876.696-2.309
TTM4.3876.722-2.335
YOY5.3667.708-2.342
5Y6.0838.390-2.307
10Y7.06211.959-4.897
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Universal Med Finl &:

  • The EOD is 5.650. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.722. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.722. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD5.650MRQ5.722-0.072
MRQ5.722TTM5.7220.000
TTM5.722YOY-5.515+11.237
TTM5.7225Y-2.807+8.529
5Y-2.80710Y-2.324-0.482
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
EOD5.650-0.494+6.144
MRQ5.722-0.546+6.268
TTM5.722-0.424+6.146
YOY-5.515-0.332-5.183
5Y-2.8070.202-3.009
10Y-2.324-0.149-2.175
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Universal Med Finl & is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Credit Services industry mean).
  • A PB ratio of 0.53 means the investor is paying $0.53 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Universal Med Finl &:

  • The EOD is 0.524. Based on the equity, the company is cheap. +2
  • The MRQ is 0.530. Based on the equity, the company is cheap. +2
  • The TTM is 0.530. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.524MRQ0.530-0.007
MRQ0.530TTM0.5300.000
TTM0.530YOY0.667-0.137
TTM0.5305Y0.728-0.198
5Y0.72810Y0.889-0.160
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
EOD0.5240.898-0.374
MRQ0.5300.849-0.319
TTM0.5300.860-0.330
YOY0.6671.105-0.438
5Y0.7281.191-0.463
10Y0.8891.296-0.407
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Universal Med Finl & compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4940.4940%-0.114+123%0.933-47%0.894-45%
Book Value Per Share--8.9358.9350%8.441+6%7.896+13%5.293+69%
Current Ratio--2.6352.6350%3.444-24%1.836+44%1.581+67%
Debt To Asset Ratio--0.7970.7970%0.789+1%0.779+2%0.796+0%
Debt To Equity Ratio--3.9183.9180%3.734+5%3.813+3%4.324-9%
Dividend Per Share--0.3320.3320%0.276+20%0.259+28%0.164+102%
Eps--1.0801.0800%1.049+3%0.939+15%0.667+62%
Free Cash Flow Per Share--0.8280.8280%-1.021+223%-1.085+231%-1.747+311%
Free Cash Flow To Equity Per Share---0.067-0.0670%0.347-119%0.011-698%0.113-159%
Gross Profit Margin--1.0001.0000%1.0000%0.848+18%0.803+25%
Intrinsic Value_10Y_max--30.749--------
Intrinsic Value_10Y_min--16.535--------
Intrinsic Value_1Y_max--0.410--------
Intrinsic Value_1Y_min---0.398--------
Intrinsic Value_3Y_max--3.267--------
Intrinsic Value_3Y_min--0.578--------
Intrinsic Value_5Y_max--8.579--------
Intrinsic Value_5Y_min--3.488--------
Market Cap8852407050.240-1%8965899448.3208965899448.3200%10649370019.840-16%10562359181.312-15%9047235666.944-1%
Net Profit Margin--0.1650.1650%0.196-16%0.223-26%0.269-39%
Operating Margin----0%-0%0.227-100%0.282-100%
Operating Ratio--1.3421.3420%1.253+7%1.008+33%0.834+61%
Pb Ratio0.524-1%0.5300.5300%0.667-20%0.728-27%0.889-40%
Pe Ratio4.332-1%4.3874.3870%5.366-18%6.083-28%7.062-38%
Price Per Share4.680-1%4.7404.7400%5.630-16%5.584-15%4.783-1%
Price To Free Cash Flow Ratio5.650-1%5.7225.7220%-5.515+196%-2.807+149%-2.324+141%
Price To Total Gains Ratio5.665-1%5.7385.7380%34.743-83%10.353-45%9.868-42%
Quick Ratio--1.0021.0020%1.249-20%2.172-54%2.401-58%
Return On Assets--0.0260.0260%0.028-8%0.028-7%0.028-10%
Return On Equity--0.1250.1250%0.132-5%0.135-7%0.153-18%
Total Gains Per Share--0.8260.8260%0.162+410%1.192-31%1.058-22%
Usd Book Value--2156604732.5832156604732.5830%2037298718.547+6%1905852769.136+13%1277450042.807+69%
Usd Book Value Change Per Share--0.0630.0630%-0.015+123%0.119-47%0.114-45%
Usd Book Value Per Share--1.1401.1400%1.077+6%1.008+13%0.675+69%
Usd Dividend Per Share--0.0420.0420%0.035+20%0.033+28%0.021+102%
Usd Eps--0.1380.1380%0.134+3%0.120+15%0.085+62%
Usd Free Cash Flow--199938639.377199938639.3770%-246371127.188+223%-261821331.891+231%-421678517.736+311%
Usd Free Cash Flow Per Share--0.1060.1060%-0.130+223%-0.138+231%-0.223+311%
Usd Free Cash Flow To Equity Per Share---0.009-0.0090%0.044-119%0.001-698%0.014-159%
Usd Market Cap1129567139.611-1%1144048769.6061144048769.6060%1358859614.532-16%1347757031.535-15%1154427271.102-1%
Usd Price Per Share0.597-1%0.6050.6050%0.718-16%0.713-15%0.610-1%
Usd Profit--270624037.840270624037.8400%268735865.292+1%237226521.964+14%166198658.533+63%
Usd Revenue--1643564174.9031643564174.9030%1367910713.189+20%1144082282.817+44%721627013.528+128%
Usd Total Gains Per Share--0.1050.1050%0.021+410%0.152-31%0.135-22%
 EOD+4 -4MRQTTM+0 -0YOY+19 -155Y+17 -1910Y+18 -18

3.2. Fundamental Score

Let's check the fundamental score of Universal Med Finl & based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.332
Price to Book Ratio (EOD)Between0-10.524
Net Profit Margin (MRQ)Greater than00.165
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.002
Current Ratio (MRQ)Greater than12.635
Debt to Asset Ratio (MRQ)Less than10.797
Debt to Equity Ratio (MRQ)Less than13.918
Return on Equity (MRQ)Greater than0.150.125
Return on Assets (MRQ)Greater than0.050.026
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Universal Med Finl & based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.540
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets76,870,771
Total Liabilities61,240,242
Total Stockholder Equity15,630,529
 As reported
Total Liabilities 61,240,242
Total Stockholder Equity+ 15,630,529
Total Assets = 76,870,771

Assets

Total Assets76,870,771
Total Current Assets69,495,118
Long-term Assets48,779,838
Total Current Assets
Cash And Cash Equivalents 3,457,729
Short-term Investments 150,000
Net Receivables 23,457,292
Inventory 375,728
Other Current Assets 937,607
Total Current Assets  (as reported)69,495,118
Total Current Assets  (calculated)28,378,356
+/- 41,116,762
Long-term Assets
Property Plant Equipment 4,935,191
Goodwill 102,253
Intangible Assets 79,173
Other Assets 1,498,085
Long-term Assets  (as reported)48,779,838
Long-term Assets  (calculated)6,614,702
+/- 42,165,136

Liabilities & Shareholders' Equity

Total Current Liabilities26,378,359
Long-term Liabilities30,789,399
Total Stockholder Equity15,630,529
Total Current Liabilities
Short-term Debt 2,518,976
Short Long Term Debt 19,994,848
Accounts payable 2,247,218
Total Current Liabilities  (as reported)26,378,359
Total Current Liabilities  (calculated)24,761,042
+/- 1,617,317
Long-term Liabilities
Long term Debt Total 29,456,778
Capital Lease Obligations Min Short Term Debt2,274,567
Long-term Liabilities Other 280,968
Long-term Liabilities  (as reported)30,789,399
Long-term Liabilities  (calculated)32,012,313
+/- 1,222,914
Total Stockholder Equity
Common Stock5,297,254
Retained Earnings 9,016,746
Other Stockholders Equity 1,316,529
Total Stockholder Equity (as reported)15,630,529
Total Stockholder Equity (calculated)15,630,529
+/-0
Other
Capital Stock5,297,254
Cash And Equivalents2,679,426
Cash and Short Term Investments 2,829,426
Common Stock Shares Outstanding 1,891,540
Liabilities and Stockholders Equity 76,870,771
Net Debt 42,463,727
Net Invested Capital 61,551,985
Net Tangible Assets 15,449,103
Net Working Capital 1,712,574
Property Plant and Equipment Gross 5,884,265



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
5,883,444
10,452,434
16,385,316
23,657,881
28,964,583
37,732,513
47,256,927
57,852,542
61,511,013
69,899,801
76,870,771
76,870,77169,899,80161,511,01357,852,54247,256,92737,732,51328,964,58323,657,88116,385,31610,452,4345,883,444
   > Total Current Assets 
0
10,150,908
4,759,911
7,963,122
8,975,980
11,927,479
14,660,581
20,714,278
21,832,527
64,511,260
69,495,118
69,495,11864,511,26021,832,52720,714,27814,660,58111,927,4798,975,9807,963,1224,759,91110,150,9080
       Cash And Cash Equivalents 
307,980
318,998
453,569
1,865,670
1,272,458
1,749,884
2,173,473
3,385,867
2,036,535
2,342,078
3,457,729
3,457,7292,342,0782,036,5353,385,8672,173,4731,749,8841,272,4581,865,670453,569318,998307,980
       Short-term Investments 
0
0
0
0
0
0
107,672
247,500
247,500
0
150,000
150,0000247,500247,500107,672000000
       Net Receivables 
0
9,580,215
15,673,881
5,919,463
26,774,412
34,592,885
43,724,724
49,830,635
54,395,732
21,046,689
23,457,292
23,457,29221,046,68954,395,73249,830,63543,724,72434,592,88526,774,4125,919,46315,673,8819,580,2150
       Other Current Assets 
0
248,374
100,685
139,678
674,080
943,706
566,148
562,182
725,782
1,089,576
937,607
937,6071,089,576725,782562,182566,148943,706674,080139,678100,685248,3740
   > Long-term Assets 
0
0
0
0
19,988,603
25,805,034
32,596,346
37,138,264
39,678,486
44,907,169
48,779,838
48,779,83844,907,16939,678,48637,138,26432,596,34625,805,03419,988,6030000
       Property Plant Equipment 
60,408
104,465
90,056
89,586
98,563
86,883
271,026
2,812,497
3,109,690
3,317,921
4,935,191
4,935,1913,317,9213,109,6902,812,497271,02686,88398,56389,58690,056104,46560,408
       Goodwill 
0
0
0
0
0
9,211
9,211
69,908
69,908
102,253
102,253
102,253102,25369,90869,9089,2119,21100000
       Long Term Investments 
0
0
20,955
64,916
64,916
43,961
81,250
481,761
0
0
0
000481,76181,25043,96164,91664,91620,95500
       Intangible Assets 
0
0
0
0
0
9,211
132,134
0
58,603
46,183
79,173
79,17346,18358,6030132,1349,21100000
       Long-term Assets Other 
0
0
0
0
3,396
4,678
9,953
44,559
58,603
6,910
19,801
19,8016,91058,60344,5599,9534,6783,3960000
> Total Liabilities 
5,027,441
9,283,691
13,957,817
17,776,681
22,390,192
30,263,687
37,000,119
44,405,334
46,545,678
55,133,972
61,240,242
61,240,24255,133,97246,545,67844,405,33437,000,11930,263,68722,390,19217,776,68113,957,8179,283,6915,027,441
   > Total Current Liabilities 
0
3,992,250
5,412,449
8,151,303
7,174,720
12,160,762
13,826,322
18,757,913
23,319,671
18,731,299
26,378,359
26,378,35918,731,29923,319,67118,757,91313,826,32212,160,7627,174,7208,151,3035,412,4493,992,2500
       Short-term Debt 
0
7,911,623
3,379,351
4,252,442
6,083,374
10,863,858
107,672
247,500
19,150,093
3,877,871
2,518,976
2,518,9763,877,87119,150,093247,500107,67210,863,8586,083,3744,252,4423,379,3517,911,6230
       Short Long Term Debt 
0
7,911,623
3,379,351
4,252,442
6,083,374
10,863,858
12,025,566
13,786,425
19,150,093
13,625,659
19,994,848
19,994,84813,625,65919,150,09313,786,42512,025,56610,863,8586,083,3744,252,4423,379,3517,911,6230
       Accounts payable 
547,054
234,597
956,422
94,773
194,333
264,697
482,381
1,289,436
868,396
1,111,983
2,247,218
2,247,2181,111,983868,3961,289,436482,381264,697194,33394,773956,422234,597547,054
       Other Current Liabilities 
0
297,525
194,441
200,344
469,070
619,981
508,421
1,176,056
1,242,897
1,332,342
0
01,332,3421,242,8971,176,056508,421619,981469,070200,344194,441297,5250
   > Long-term Liabilities 
0
0
0
0
15,215,472
18,102,925
23,173,797
25,647,421
23,226,007
33,545,247
30,789,399
30,789,39933,545,24723,226,00725,647,42123,173,79718,102,92515,215,4720000
       Long term Debt Total 
0
0
0
9,457,629
14,966,715
17,799,713
22,728,404
25,017,184
22,397,759
29,426,750
29,456,778
29,456,77829,426,75022,397,75925,017,18422,728,40417,799,71314,966,7159,457,629000
       Capital Lease Obligations Min Short Term Debt
0
-7,911,623
-3,379,351
-4,252,442
-5,881,845
-9,368,682
1,220,941
2,872,742
-16,976,016
-1,977,964
2,274,567
2,274,567-1,977,964-16,976,0162,872,7421,220,941-9,368,682-5,881,845-4,252,442-3,379,351-7,911,6230
       Long-term Liabilities Other 
0
0
0
0
64,916
43,961
0
0
0
257,200
280,968
280,968257,20000043,96164,9160000
> Total Stockholder Equity
856,003
1,168,743
2,427,499
5,881,200
6,574,391
7,468,601
10,048,092
11,141,691
12,422,901
14,765,829
15,630,529
15,630,52914,765,82912,422,90111,141,69110,048,0927,468,6016,574,3915,881,2002,427,4991,168,743856,003
   Common Stock
775,291
775,291
1,579,905
4,327,842
4,327,842
4,327,842
4,327,842
4,327,842
4,327,842
5,297,254
5,297,254
5,297,2545,297,2544,327,8424,327,8424,327,8424,327,8424,327,8424,327,8421,579,905775,291775,291
   Retained Earnings 
80,517
393,255
841,629
1,524,110
2,183,999
3,078,209
4,078,048
5,159,574
6,352,994
7,705,246
9,016,746
9,016,7467,705,2466,352,9945,159,5744,078,0483,078,2092,183,9991,524,110841,629393,25580,517
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
197
5,965
29,248
62,550
62,550
1,642,202
1,654,275
1,742,065
1,763,329
1,316,529
1,316,5291,763,3291,742,0651,654,2751,642,20262,55062,55029,2485,9651970



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue11,912,140
Cost of Revenue-7,426,151
Gross Profit4,485,9894,485,989
 
Operating Income (+$)
Gross Profit4,485,989
Operating Expense-8,559,721
Operating Income2,726,143-4,073,732
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,651,783
Selling And Marketing Expenses0
Operating Expense8,559,7211,651,783
 
Net Interest Income (+$)
Interest Income21,857
Interest Expense-214,184
Other Finance Cost-230,971
Net Interest Income38,644
 
Pretax Income (+$)
Operating Income2,726,143
Net Interest Income38,644
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,704,2862,726,143
EBIT - interestExpense = -214,184
2,578,174
2,175,599
Interest Expense214,184
Earnings Before Interest and Taxes (EBIT)02,918,470
Earnings Before Interest and Taxes (EBITDA)3,177,956
 
After tax Income (+$)
Income Before Tax2,704,286
Tax Provision-616,759
Net Income From Continuing Ops2,087,5272,087,527
Net Income1,961,415
Net Income Applicable To Common Shares1,890,012
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-38,644
 

Technical Analysis of Universal Med Finl &
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Universal Med Finl &. The general trend of Universal Med Finl & is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Universal Med Finl &'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Universal Med Finl &.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.85 < 5.0110554493308.

The bearish price targets are: 4.58 > 4.54 > 4.34.

Tweet this
Universal Med Finl & Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Universal Med Finl &. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Universal Med Finl & Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Universal Med Finl &.

Universal Med Finl & Daily Moving Average Convergence/Divergence (MACD) ChartUniversal Med Finl & Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Universal Med Finl &. The current adx is .

Universal Med Finl & Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Universal Med Finl &.

Universal Med Finl & Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Universal Med Finl &.

Universal Med Finl & Daily Relative Strength Index (RSI) ChartUniversal Med Finl & Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Universal Med Finl &.

Universal Med Finl & Daily Stochastic Oscillator ChartUniversal Med Finl & Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Universal Med Finl &.

Universal Med Finl & Daily Commodity Channel Index (CCI) ChartUniversal Med Finl & Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Universal Med Finl &.

Universal Med Finl & Daily Chande Momentum Oscillator (CMO) ChartUniversal Med Finl & Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Universal Med Finl &.

Universal Med Finl & Daily Williams %R ChartUniversal Med Finl & Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Universal Med Finl &.

Universal Med Finl & Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Universal Med Finl &.

Universal Med Finl & Daily Average True Range (ATR) ChartUniversal Med Finl & Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Universal Med Finl &.

Universal Med Finl & Daily On-Balance Volume (OBV) ChartUniversal Med Finl & Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Universal Med Finl &.

Universal Med Finl & Daily Money Flow Index (MFI) ChartUniversal Med Finl & Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Universal Med Finl &.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Universal Med Finl & Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Universal Med Finl & based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.540
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Universal Med Finl & with someone you think should read this too:
  • Are you bullish or bearish on Universal Med Finl &? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Universal Med Finl &? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Universal Med Finl &

I send you an email if I find something interesting about Universal Med Finl &.


Comments

How you think about this?

Leave a comment

Stay informed about Universal Med Finl &.

Receive notifications about Universal Med Finl & in your mailbox!